Evidence map›Paper›PMID 39001309›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Frailty as an Independent Predictor of Adverse Outcomes in Patients Undergoing Direct Myocardial Revascularization.

Kristina Krivoshapova, Daria Tsygankova, Evgeny Bazdyrev, Olga Barbarash

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kristina KrivoshapovaFederal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Kemerovo 650002, Russia.ORCID 0000-0003-2384-5682
Daria TsygankovaFederal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Kemerovo 650002, Russia.
Evgeny BazdyrevFederal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Kemerovo 650002, Russia.ORCID 0000-0002-3023-6239
Olga BarbarashFederal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Kemerovo 650002, Russia.ORCID 0000-0001-6981-9661

Funding

Russian Science Foundation 22-15-00305
6 · The paper itself

Abstract

The aim of this study was to analyze the incidence and anamnestic characteristics of frail patients with stable coronary artery disease (CAD) and to evaluate the role of frailty in the development of complications and adverse outcomes in the perioperative period and early survival period after coronary artery bypass grafting (CABG). MATERIAL AND

methodsThe study included 387 patients admitted to the clinic for a scheduled primary CABG. A seven-item questionnaire, "PRISMA-7", was used to identify frail elderly patients before the procedure. We divided the study sample into two groups, taking into account the results of the survey: patients without frailty, n

resultsWe detected frailty in 22.5% of the patients with CAD before the procedure. According to the anamnestic data and paraclinical and intraoperative findings, the groups of patients with and without frailty were comparable. The differences were revealed in the intraoperative and early postoperative periods of CABG. Thus, postoperative rhythm disturbances (19.5% vs. 10.5%,

conclusionThe presence of frailty can be used as an independent predictor of an unfavorable prognosis in patients with CAD, both in the perioperative and early survival period after CABG. It should be taken into account during surgical risk assessment.

Indexed as

adverse outcomecoronary artery bypass graftingcoronary artery diseasefrail patientsfrailty

Identifiers

PMID39001309
PMCPMC11241404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.